Ace Vision Group
Manufacturing · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1 Boston Pl Ste 2600, Boston, Massachuse...Phone Number
(617) 621-7000Website
www.acevisiongroup.comRevenue
$9.8 MillionIndustry
About Ace Vision Group
Ace Vision Group, Inc. is an innovative ophthalmic laser device company focused on developing touchless eye laser therapy for individuals experiencing age-related vision loss, particularly presbyopia, which affects billions globally. Their flagship product, Laser Scleral Microporation (LSM), is currently undergoing pilot clinical trials outside the United States and aims to revolutionize eye care. The company collaborates with leading eye care professionals to advance their treatments and enhance patient outcomes. Although not yet FDA approved, they are inviting healthcare providers and potential patients to join their efforts in pioneering this new therapy.Explore more
Ace Vision Group Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Ace Vision Group
Compare insights from companies similar to Ace Vision Group, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Ace Vision Group Tech Stack
A closer look at the technologies used by Ace Vision Group
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Ace Vision Group
Sign Up For FreeTo access detailed company insights
Ace Vision Group, Inc. is an innovative ophthalmic laser device company focused on developing touchless eye laser therapy for individuals experiencing age-related vision loss, particularly presbyopia, which affects billions globally. Their flagship product, Laser Scleral Microporation (LSM), is currently undergoing pilot clinical trials outside the... Read More
